Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE787.2062.6 (+8.64 %)

PREV CLOSE ( ) 724.60

OPEN PRICE ( ) 774.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 33162

TODAY'S LOW / HIGH ( )754.20 794.80

52 WK LOW / HIGH ( )597.95 876.75

NSE787.1063.75 (+8.81 %)

PREV CLOSE( ) 723.35

OPEN PRICE ( ) 750.00

BID PRICE (QTY) 787.10 (214)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 702089

TODAY'S LOW / HIGH( ) 750.00 794.00

52 WK LOW / HIGH ( )598.6 875.65

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-11 2006

Management Info

Gangadi Madhukar Reddy - Chairman Gangadi Madhukar Reddy - Managing Director

Registered Office

Address H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, Kukatpally,
Hyderabad,
Telangana-500037

Phone 040-67246724

Email medplus@medplusindia.com

Website www.medplusindia.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

01Feb Medplus Health Services reports over 3
Medplus Health Services has reported results for third quarter ended Dec..

03Jan Medplus Health Services informs about
Medplus Health Services has informed that the exchange has received the..

01Jan Medplus Health Services informs about
Medplus Health Services has informed that the exchange has received the..

28Dec Medplus Health Services informs about
Medplus Health Services has informed that it enclosed disclosure under R..

28Dec Medplus Health Services informs about
Medplus Health Services has informed that the exchange has received the..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	93.6899999999999	95.8099999999992
Gross Profit	120.3	70.4099999999992
Operating Profit	208.83	396.129999999999
Net Sales	1767.93	4670.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 7441.40 (2.96%)	M.Cap ( in Cr)18603.50
Wockhardt (BSE) 1557.15 (10.00%)	M.Cap ( in Cr)25299.38
Suven Pharma (BSE) 1108.25 (4.99%)	M.Cap ( in Cr)28212.16
Bajaj Healthcare (BSE) 690.80 (8.20%)	M.Cap ( in Cr)2181.77
Divi's Lab (BSE) 5622.30 (0.83%)	M.Cap ( in Cr)149254.40

Shareholding Pattern

	PROMOTERS	40.39%
	MUTUAL FUNDS/UTI	21.51%
	NON-INSTITUTION	18.73%
	FI/BANKS/INSURANCE	2.47%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	3.32
Nippon India Focuse...	2.13
Bandhan Innovation ...	1.66
ICICI Pru Pharma He...	1.56
JM Aggressive Hybri...	1.53
Bandhan Hybrid Equi...	0.99
Tata India Pharma &...	0.77

Risk Disclosures on Derivatives

Smart Quotes

MEDPLUS HEALTH SERVICES LTD.